# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-22-133655
Filing Date
2022-04-29
Accepted
2022-04-29 16:10:48
Documents
3

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFA14A | d625895ddefa14a.htm | DEFA14A | 9851
2 | GRAPHIC | g625895g00a55.jpg | GRAPHIC | 331428
3 | GRAPHIC | g625895g00a56.jpg | GRAPHIC | 256140
| Complete submission text file | 0001193125-22-133655.txt |  | 820458

Mailing Address 421 KIPLING STREET PALO ALTO CA 94301
Business Address 421 KIPLING STREET PALO ALTO CA 94301 (650) 391-9740
BridgeBio Pharma, Inc. (Filer) CIK: 0001743881 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38959 | Film No.: 22875415
SIC: 2834 Pharmaceutical Preparations